PRKCZ Gene: Protein Kinase C Zeta – Function, Disease Associations, and Expression

Comprehensive biomedical overview of PRKCZ (PKCζ), including genomic data, expression profiles, mutations, and clinical relevance.

Gene Information Card

Symbol PRKCZ
Full Name Protein Kinase C Zeta
Gene Type Protein coding
Chromosomal Location 1p36.33-p36.32
NCBI Gene ID 5590 ncbi.nlm.nih.gov/gene/5590
Ensembl ID ENSG00000067606
UniProt ID Q05513
OMIM ID 176982
HGNC ID 9412
Aliases PKC-ZETA, PKC2, aPKCζ

Description

PRKCZ encodes protein kinase C zeta (PKCζ), an atypical member of the protein kinase C (PKC) family. Unlike conventional PKCs, PKCζ is not activated by calcium or diacylglycerol but is regulated by phosphorylation and protein-protein interactions. It plays critical roles in cell survival, proliferation, differentiation, and immune responses, particularly through NF-κB signaling and insulin signaling pathways. PRKCZ is involved in the regulation of glucose metabolism, neuronal function, and inflammatory responses. Dysregulation of PRKCZ has been implicated in various cancers, metabolic disorders, and neurological conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 2 Diabetes Impaired insulin signaling due to reduced PKCζ activity in skeletal muscle and adipose tissue ClinVar, PMID: 15115830
Alzheimer's Disease Altered PKCζ activity affects tau phosphorylation and synaptic plasticity ClinVar, PMID: 21907139
Schizophrenia Genetic variants in PRKCZ associated with altered brain expression and cognitive function ClinVar, PMID: 21383955
Breast Cancer Overexpression of PKCζ promotes cell proliferation and invasion via NF-κB activation COSMIC, PMID: 20628033
Non-small Cell Lung Cancer Increased PKCζ expression correlates with poor prognosis and chemoresistance COSMIC, PMID: 23569385
Inflammatory Bowel Disease PKCζ regulates intestinal epithelial barrier integrity and inflammation ClinVar, PMID: 24013265

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.3 Medium
Heart 8.7 Low
Liver 6.2 Low
Kidney 9.5 Low
Lung 7.8 Low
Skeletal Muscle 5.4 Low
Adipose Tissue 10.1 Medium
Pancreas 7.0 Low
Spleen 11.2 Medium
Thymus 9.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical cancer cell line; high expression
A549 12.8 Lung carcinoma; moderate expression
MCF7 14.5 Breast cancer; high expression
HepG2 10.3 Hepatocellular carcinoma; moderate expression
SH-SY5Y 13.1 Neuroblastoma; high expression
Jurkat 11.7 T cell leukemia; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1138C>T (p.Arg380Cys) Missense 0.01% (gnomAD) Reduced kinase activity; associated with insulin resistance
c.1573G>A (p.Glu525Lys) Missense 0.005% (gnomAD) Altered substrate specificity; potential gain-of-function in cancer
c.1960A>G (p.Ile654Val) Missense 0.02% (gnomAD) No known clinical significance
c.2146C>T (p.Arg716Trp) Missense 0.003% (gnomAD) Impaired protein stability; linked to neurological phenotypes
c.2290G>A (p.Glu764Lys) Missense 0.001% (COSMIC) Somatic mutation in colorectal cancer; potential oncogenic role
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Arg380Cys reduce kinase activity, impairing insulin signaling and NF-κB activation, leading to metabolic dysfunction.

Gain of Function (GOF)

Certain somatic mutations (e.g., p.Glu764Lys) may enhance kinase activity, promoting cell proliferation and survival in cancers.

Dominant Negative (DN)

Some mutations may produce a dominant-negative effect, interfering with wild-type PKCζ function in signaling complexes.

Gene Ontology (GO)

• ATP binding • protein kinase activity
• protein serine/threonine kinase activity • signal transducer activity
• zinc ion binding • identical protein binding
• protein kinase C activity • NF-κB binding
• insulin receptor binding • tau protein binding

Pathways

NF-κB signaling pathway
Insulin signaling pathway
ErbB signaling pathway
T cell receptor signaling pathway
Fc epsilon RI signaling pathway
Neurotrophin signaling pathway
Sphingolipid signaling pathway
Regulation of actin cytoskeleton

Protein Summary

Protein kinase C zeta (PKCζ) is a 67.7 kDa serine/threonine kinase composed of 592 amino acids. It contains an N-terminal PB1 domain, a C2-like domain, and a C-terminal kinase domain. PKCζ is atypical as it lacks the calcium-binding C2 domain and the diacylglycerol-binding C1 domain found in conventional PKCs. It is activated by phosphorylation at Thr410 and Thr560, and by interaction with proteins such as Par6 and p62. PKCζ regulates diverse cellular processes including glucose transport, cell polarity, and immune responses. Its activity is tightly controlled by phosphorylation, ubiquitination, and protein-protein interactions.

Related Products

Product name Cat.No. Species Gene ID
PRKCZ Knockout HEK293 Cell Line EDJ-KQ1346 Human 5590 Details Get a Quote
PRKCZ Knockout A-549 Cell Line EDJ-KQ20815 Human 5590 Details Get a Quote
PRKCZ Knockout HCT 116 Cell Line EDJ-KQ20816 Human 5590 Details Get a Quote
PRKCZ Knockout HeLa Cell Line EDJ-KQ20817 Human 5590 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: